An industry update: what is the latest news in therapeutic delivery?

@article{Simpson2017AnIU,
  title={An industry update: what is the latest news in therapeutic delivery?},
  author={Iain Simpson},
  journal={Therapeutic delivery},
  year={2017},
  volume={8 8},
  pages={607-613}
}
This Industry Update covers the period from 1 through 30 April 2017, and is based on information sourced from company press releases, scientific literature, patents and various news websites. Biogen expanded its portfolio of developmental drugs targeting neurological diseases by licensing a drug from Bristol-Myers Squibb which is currently under… CONTINUE READING